the precise solution by sfm
How can a mixing and transfer device offer users more benefits and enhance usability through optimized user-friendliness? These were the questions we thoroughly considered when embarking on the development of the nextaro® product family. The results of our efforts had already convinced us for quite some time, and positive feedback from the market now confirms the advantages of nextaro®.
Octapharma, one of the world’s leading pharmaceutical companies specializing in the development, production, and distribution of drugs for treating various blood coagulation disorders, conducted a comparative study. The aim was to compare the user-friendliness and design of nextaro® with the existing Mix2Vial system. Both systems were evaluated for the reconstitution of coagulation factor products, among others, a four-Factor Prothrombin Complex Concentrate (Octaplex®/Balfaxar®). With positive results! The study revealed a 40% higher preference among users for the new nextaro® compared to the previous transfer system. The following factors were specifically compared:
The study results were presented at the 18th World Congress of Anesthesiology in Singapore (#WCA2024). You can find more information on the study publication at www.wac2024.org.
We take pride in supporting Octapharma’s life-saving and high-value medications through our nextaro® product family during their application. Our longstanding partnership has led to significant advancements, and we remain committed to excellence. With a focus on people’s health and quality of life, Octapharma combines its high-quality medications with the transfer devices they deserve!
The nextaro® product family continues to grow steadily. The new developments are oriented towards the wishes and needs of the market. The focus of the product family lies in the highest quality solutions for the user and patient.
We are pleased to announce that our innovative medical product nextaro® has been successfully approved in Canada. This further milestone represents an important step in our international expansion and confirms the quality and recognition of our product.
Medical device approval in Canada requires thorough review and compliance with strict regulatory requirements. Our team worked closely with Canadian health authorities to submit all required…
In recent years, sustainability has become increasingly important in the medical industry. In particular, companies are increasingly focusing on the development and manufacture of sustainable medical products.
Top off your high quality application set with the device it deserves.
Please do not hesitate to contact us.
nextaro® is manufactured and distributed by:
sfm medical devices GmbH, Brückenstraße 5, 63607 Wächtersbach (Germany)
